Adenocarcinoma
Occupational benzene exposure heightens lung cancer likelihood
Gastric Adenocarcinoma
Gastric Adenocarcinoma
Why am I so darn tired?
Q&A: non-endoscopic detection for BE, esophageal adenocarcinoma
Speaker: Rationale exists to test CAR T-cell therapy in KRAS-mutated lung cancer
BARCELONA — Enriched cell surface expression of mesothelin in KRAS-mutated adenocarcinoma and supporting preclinical evidence suggest chimeric antigen receptor T-cell therapy targeting mesothelin may be feasible and efficacious for this group of patients, according to a presentation at International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Survey reveals ‘suboptimal awareness’ of lung cancer molecular testing guidelines
Barrett’s with indefinite for dysplasia carries risk for progression
Patients with Barrett’s Esophagus with indefinite for dysplasia are at similar risk for malignant progression and should be screened like patients with low-grade dysplasia, according to results of a meta-analysis published in Gastrointestinal Endoscopy. “Currently, there are no reliable estimates for progression risk to [high-grade dysplasia/esophageal adenocarcinoma (HGD/EAC)] in patients with [Barrett’s esophagus with indefinite for dysplasia (BE-IND)],” Prasad G. Iyer, MD, MSc, from the division of gastroenterology and hepatology at Mayo Clinic in Rochester, Minnesota, and colleagues wrote. “Hence, management strategies for BE-IND are unclear and endoscopy is not routinely recommended.”
Part of the Healio Network
Marantic Endocarditis
Marantic endocarditis (a.k.a. non-bacterial thrombotic endocarditis or NBTE) occurs from deposition of thrombus and fibrinous material on the heart valves, most commonly the mitral valve.